Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $213,910 - $239,505
-1,685 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$131.15 - $144.24 $123,674 - $136,018
943 Added 127.09%
1,685 $235,000
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $7,668 - $8,527
61 Added 8.96%
742 $104,000
Q3 2018

Nov 14, 2018

BUY
$121.58 - $142.88 $72,583 - $85,299
597 Added 710.71%
681 $94,000
Q1 2018

May 15, 2018

SELL
$125.1 - $148.14 $41,032 - $48,589
-328 Reduced 79.61%
84 $11,000
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $11,153 - $12,207
85 Added 25.99%
412 $58,000
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $42,336 - $44,269
327
327 $43,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $397B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Magellan Asset Management LTD Portfolio

Follow Magellan Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Magellan Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Magellan Asset Management LTD with notifications on news.